FFAR1 and neurodegenerative disease: Although the exact mechanism how GLP-1 and GPR40 agonist improve neurodegeneration is still elusive, it appears that gut-restricted GPR40 agonist might have the potential for the treatment of neurodegenerative diseases, pending the clinical results of Semaglutide for Alzheimer’s disease.